logo-loader

Buds & Duds: Market conditions worsen for cannabis companies but Canntab Therapeutics soars on new joint venture agreement

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada sank 3.7% to 141.07 points. The OTCQX Cannabis Index slipped 2.6% to 515.3 points.

Buds today were Canntab Therapeutics Limited (CSE:PILL) (OTCMKTS:CTABF), Lexaria Bioscience Corp (CSE:LXX) (OTCMKTS:LXRP). The duds were MedMen Enterprises Inc (CSE:MMEN) (OTCMKTS:MMNFF), Aphria Inc (TSE:APHA). 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Canntab Therapeutics Ltd named herein, including the promotion by the Company of Canntab Therapeutics Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Preveceutical announces successful preliminary evaluation of...

Preveceutical (CSE:PREV-OTCQB: PRVCF) President Mak Jawadeker joined Steve Darling from Proactive Vancouver on Skype to discuss the company successfully completing the design, synthesis and preliminary evaluation of key peptides from its scorpion venom-derived peptide research and development...

2 days ago

2 min read